@_backtableONC knows how to put on a production 👏👏 pleasure sitting down w/two #KOLs & friends in #GIonc @IbrahimSahinMD1 @AGangiMD to talk #periop #CRC Download the Backtable app❗️ @AaronFrittsMD More #GIonc ep coming❗️ @ronanhsieh @DaniCastilloMD @Ahn_Daniel_Onc @AlgazeMD

How should patients be monitored after treatment for gynecologic cancer? UCLA’s Dr. Ritu Salani joins the latest @_backtableONC podcast to discuss updated surveillance guidelines, early detection & the challenges of post-treatment care. Listen here: bit.ly/4xLiNlJ

Side effects labeled “low grade” can still disrupt daily life, so listening directly to patients is essential to understanding how tolerable a treatment truly is. Researchers, clinicians, and advocates need to keep asking how persistent symptoms affect daily functioning, independence, and quality-of-life and then use that information to support better care decisions. In a LUNGevity-supported study, 81 of 394 participants reported persistent low-grade diarrhea and they shared their lived experiences with the “low grade” side effect. These findings reinforce the importance of patient-reported symptoms in revealing burdens that may not be apparent in clinical reporting alone. Learn more about this research here: lungevity.org/blogs/what-is-… This research was highlighted as an oral presentation at the 2026 World Conference on Lung Cancer. @BellKingKal #WCLC26

How can reconstructive urologists bridge the quality of life gap for cancer survivors? This week on BackTable Urology, join Dr. George Koch (@_KochDoc) and Dr. Hiren Patel (@hirenpMD) as they examine survivorship in urologic care and the important role reconstructive urologists have in addressing patient quality of life concerns after cancer treatment. Stay tuned for the end of the episode where Dr. Patel overviews a robotic ureteral reconstruction case performed via a single-port! Access the full episode here: na2.hubs.ly/H07Z_Tq0 #URO330 #Urology #GURS @OSU_Urology @uwurology @UCSFUrology @RuchikaTalwarMD

Structured exercise matched the disease-free survival (DFS) benefit of adjuvant oxaliplatin. 🏃 Dr. Jun Gong (@jgong15), Dr. Ibrahim Sahin (@IbrahimSahinMD1) and Dr. Alexandra Gangi (@AGangiMD) on CHALLENGE, ATOMIC, ctDNA after liver resection, and transplant for unresectable colorectal cancer (CRC). Watch the full episode on the BackTable App: na2.hubs.ly/H07-0ss0 #ONC82 #Oncology #ColorectalCancer #GIOncology @CedarsSinai @UMRogelCancer @ASCO @myESMO

Dr. Lindsay Peterson asks neuro-oncologist @barbaraobrienmd how common are brain mets in breast ca, and how has the prognosis changed in the last 5 years? @MDAndersonnews @SitemanCenter @WashUOncology Full episode here👉backtable.com/shows/tumor-bo…

How do you approach a T3N0 laryngeal cancer with erosion of the thyroid cartilage? This week’s Case Highlight features Drs. Dylan Roden, Ravindra Uppaluri (@DrUppaluri), and Adam Luginbuhl discussing treatment considerations for an anterior laryngeal cancer with thyroid cartilage involvement. Explore this case and more clinical discussions in the BackTable App: backtable.com/shows/ent/case… #ENT #HeadAndNeckCancer #LaryngealCancer #Oncology @KimmelCancerCtr @Jefferson_OTO @hncalliance @gopibshah

Congratulations to @GTumors on launching PCARE. People with penile cancer and their caregivers need support that is specific to their disease, especially in a rare cancer where local resources may be thin.

Amazing to see our phase I high-dose L-Gln story in #mPDAC picked up by several outlets incl @TheCancerLetter @KnowridgeSci @EpochTimes @medical_xpress cancerletter.com/clinical-ro… knowridge.com/2026/09/unexpe… nutraingredients.com/Article… theepochtimes.com/health/com… medicalxpress.com/news/2026-…

PCPs can help more people access lifesaving lung cancer screening. But 80% of surveyed PCPs want more education on lung cancer screening. We have heard this need and we are building education, navigation, and referral support, so that more people can be diagnosed earlier when lung cancer is most treatable. Learn more about this research: lungevity.org/blogs/do-prima… This work was presented at the 2026 World Conference on Lung Cancer. @MontefioreNYC @BrendonStilesMD @nchudgar #WCLC26

What’s the best move for a patient with multifocal HCC and borderline liver function? Dr. Beau Toskich (@BeauToskichMD), Dr. Lingling Du, and Dr. Tyler Sandow (@bayouteazy) break down how they choose between Y90 and immunotherapy, why portal hypertension is a critical factor, and why it all comes down to nuanced, case-by-case decisions. Access the full episode in the BackTable app: backtable.com/shows/vi/podca… This podcast is supported by an educational grant from Sirtex and Boston Scientific. #VI659 #HCC #Y90 #HCCCreatorWeekend #Immunotherapy @MayoClinicFL_IR @OchsnerHealth @AaronFrittsMD @beckcj

How does the reality of transurethral removal of bladder tumor procedure (TURBT) compare to its reputation as a simple procedure? Dr. Charles Peyton (@ccp1983) and Dr. Ruchika Talwar (@RuchikaTalwarMD) explore bleeding, anxiety, and the financial fallout that patients face with recurring bladder tumor resections. Access the full episode in the BackTable app: backtable.com/shows/urology/… #URO323 #BladderCancer #NMIBC #TURBT @VUMCDiscoveries @UABUrology

clinical-grade oral L-glutamine formulation as a therapeutic sensitizer to standard chemotherapy in advanced PDAC patients.@oncodaily @OncoAlert @_backtableONC

Is the era of cisplatin over? The latest #BackTableTumorBoard features @AlanTanMD, Dr. Amanda Nizam, and Dr. Brad McGregor discussing the rapidly shifting MIBC landscape. Listen now: na2.hubs.ly/H03j5v90 #BladderCancer #OncTwitter #Immunotherapy #ONC45 #GUOnc

How do you approach radiation treatment when a lung nodule is difficult to localize? This week’s Case Highlight features Drs. Alan Lee, Scott Oh, Robert Suh, Scott Genshaft, and Venkatesh Krishnasamy (@kavikrishVIR) discussing radiation treatment of an elusive lung nodule in a 56-year-old patient with NSCLC. Explore this case and more clinical discussions in the BackTable App: backtable.com/shows/tumor-bo… #LungCancer #NSCLC #RadiationOncology #InterventionalOncology @Kate_Baker_MD @UCLAHealth @uabmedicine

How do you get a sample from even the toughest bone lesions? Dr. Peter Thurlow and Dr. Neil Jain (@DigitalAngio) explain why CT is their go-to, when ultrasound can work, and how needle trajectory software and 3D reconstructions make tough access safer and more precise. Access the full episode in the BackTable app: backtable.com/shows/vi/podca… This podcast is supported by Varian OmniBone. #VI665 #MSK106 #BoneBiopsy #OrthopedicOncology #BoneTumor @UWMedicine @_backtableMSK @Georgetown_IR @NJIRSociety @beckcj

How do you counsel patients about efficacy and real-world side effects of Gem-iDRS? Dr. Sarah Psutka (@spsutkaMD) and Dr. Ruchika Talwar (@RuchikaTalwarMD) break down trial results, FDA approval criteria, and their go-to strategies for managing urinary symptoms and keeping patients on track with therapy. Access the full episode in the BackTable app: backtable.com/shows/urology/… This podcast is supported by Johnson & Johnson. #URO320 #BladderCancer #NMIBC #IntravesicalTherapy @VUMChealth @uwurology @EUplatinum

Weekly thoracentesis is a revolving door. When should you place a tunneled catheter? Dr. Neil Jain (@DigitalAngio) talks with Dr. Marco Ertreo about pleural and abdominal drains, Tenckhoff versus PleurX, and why TIPS comes first for cirrhosis patients. Watch the full episode on the BackTable App: backtable.com/shows/vi/podca… #VI676 #InterventionalRadiology #PleuralEffusion #Ascites #TIPS @Georgetown_IR @NJIRSociety @beckcj @SDhandMD

How can urologists move past a one-size-fits-all approach to PSA? Dr. Tarik Benidir (@TarikBenidir) and Dr. Ruchika Talwar (@RuchikaTalwarMD) discuss smarter use of repeat testing, patient education, and why age and prostate size are key context clues. Access the full episode in the BackTable app: backtable.com/shows/urology/… This podcast is supported by Cleveland Diagnostics. #URO325 #ProstateCancer #PSATesting #ProstateBiopsy #UrologicOncology @UF_Urology @VUMChealth

Moores Cancer Center member Ludmil Alexandrov, PhD, shares his research and vision for the future of cancer prevention in a new Q&A with Cancer Grand Challenges. Learn more about his work and the global initiative advancing cancer research. Full Article: bit.ly/4xAzOih